Recursion Pharmaceuticals, Inc. (RXRX)
RXRX price $3.64 -0.02 -0.55%
- Ticker
- RXRX
- Price
- $3.64
- Change
- -0.02 -0.55%
- Market cap
- $1.95B
- P/E
- -3.52
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 47
Recursion Pharmaceuticals, Inc. operates as a biotechnology firm currently in its clinical development phase. The company's mission is to revolutionize drug discovery by decoding biological processes, utilizing an integrated approach that combines technological innovations across biology, chemistry, automation, data science, and engineering. Their developmental pipeline features several clinical-stage compounds…